WASHINGTON - U.S. regulators on Monday authorized the emergency use of Pfizer Inc.'s coronavirus vaccine for adolescents as young as 12 years old, lowering the minimum age from 16.
Sorry. This article is no longer available.
Sorry, this article was first published more than three months ago and is temporarily unavailable.
Once the upcoming introduction of a paid membership system is fully operational, paid members will have access to all our stories.
Free Membership Provides
Newsletter from Editorial Team and access to archive articles from past three months.
By continuing, you agree to the Terms of Use,
and Privacy Policy.
